- Greek Exit Could Trigger 50% Fall in Euro Stocks: Analyst
- Big Stock Upside for Hudson City Deal: Analyst
- 5 High-Yield Stocks Ready to Boost Dividends
- Option Bulls Take Another Shot on Idenix
- Top 20 European Stocks for Crisis Time: Strategist
- Hewlett-Packard Faces a ‘Dogfight’ for Talent: Analyst
- DuckDuckGo Cooks Google’s Goose: Analyst
- General Electric’s $4.5 Billion Dividend Slated for Buybacks
- Dell Has Worst Day in 11 Years, Volume Jumps
- What Would it Take for Facebook to Eclipse Visa's Record IPO?
- Gold Turns Negative for 2012
- The Worst-Performing Energy Stocks This Week
- Papa Johns Hits Record High, Volume Spikes
- S&P 500 Earnings: Biggest Surprises
- Big Lots Has Worst Day Since 2008, Breaks Technical Level
- BP Oil Disaster: Two Years Later
- eBay Has Best Day Since 2008, Volume Spikes
- Here are Today's Winners on the Biotech Index
- Citigroup Lost $20 Million on Facebook IPO Trades
- Sticker Shock: What College Is Likely to Cost in 18 Years
- JPMorgan to Shake Up Risk Team After Big Loss: Report
- Icahn Raises Stake in Chesapeake, Wants Board Seats
- Marc Faber: Chance of Global Recession Is Now 100%
- Week Ahead: Europe Has Wall Street Bull on Short Leash
- What Happened to Stocks? Most Unloved in 50 Years
- Cool Jobs: From Gold Stacker to Bed Tester
- Many Greeks Moved Their Money Abroad Long Ago
MOST SHARED
- Marc Faber: 100% Chance of Global Recession
- Time for Flash Sales to Adapt or Die
- How to Trade on the Jobs Report
- Citigroup Lost $20 Million on Facebook IPO Trades
- Don’t Trust Buybacks
- Buy Broken Stocks, Not Broken Companies
- The Biggest Market Myth There Is?
- Facebook: The Song — Yes, We're Serious
- Under Pressure, FHA Skews to Wealthier Home Buyers
- Buying the Right Sell-Off Stocks
MOST POPULAR
HOT ON FACEBOOK
Stock Picks Your Portfolio Might Love
Text Size 
Stocks are down this Valentine's Day, and there's nothing to love about that.
To keep investors from getting their hearts broken by their portfolios, CNBC enlisted the help of market experts.
Bullish on AJG
“That’s the No. 4 company in the industry. We do like the industry, even though the price is soft right now. We think [Arthur J.] Gallagher [AJG
Loading...
()
] is well positioned to do very well in the next several years. It’s a high-recurring revenue business; great return on invested capital, key-metric of Fiduciary Management that we look for of over 15%, stock yields are almost 5%. The internal growth rate of this company is somewhere about 3-4%. With acquisitions this probably gets us up to 5-6% growth plus the dividends.”
Ted Kellner, Fiduciary Management
______________________________________
Down market? Trade up with CNBC's experts:
 |
______________________________________
Betting on Biotech
“The reason I like Genentech short-term is on February 23 they’re awaiting approval on their Avastin drug for breast cancer. Most investors don't think this drug is going to get approved, therefore if it doesn't, I don't think the stock falls all that much next week. If it does get approved, however, the stock's up a lot, and I think it's got a decent shot at getting approved."
Mark Schoenebaum, Bear Stearns Biotech Analyst
Schoenebaum recommends: Genentech [DNA
Loading...
()
], Amgen [AMGN
Loading...
()
] and Human Genome Sciences [HGSI
Loading...
()
]
(Contd.)
______________________________________
______________________________________
The Case for Comcast
“We think that Comcast is worth in the high 20s, low 30s, so today would just be the tip of the iceberg. What’s interesting about it, is they had an earnings beat, but their guidance for next year was not particularly wonderful, but the stock is up because expectations were so low…They’re a little more focused on shareholders, they did start a dividend, which is their first ever, they’ll increase that over time, they increased their share buyback and committed to the timeframe.”
David Katz, Matrix Asset Advisors Chief Investment Officer
Katz recommends: Comcast [CMCSK
Loading...
()
] and AIG [AIG
Loading...
()
]
Data is a real-time snapshot *Data is delayed at least 15 minutes
